Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AG01 |
Synonyms | |
Therapy Description |
AG01 is a monoclonal antibody that targets progranulin (GP88), potentially leading to inhibition of tumor cell proliferation and decreased tumor growth (PMID: 33616772). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AG01 | AG-01|AG 01 | AG01 is a monoclonal antibody that targets progranulin (GP88), potentially leading to inhibition of tumor cell proliferation and decreased tumor growth (PMID: 33616772). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05627960 | Phase I | AG01 | First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies | Recruiting | USA | 0 |